Zika virus (ZIKV) infection during pregnancy has been linked to severe birth defects, and the epidemiologic situation of the ZIKV epidemic in Ecuador is poorly understood.
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Guayaquil, Ecuador, has a tropical climate and experiences frequent outbreaks of dengue and chikungunya virus, and in December 2015, ZIKV was identified. Given the well-documented effects of ZIKV in pregnancy, including microcephaly, we tested for the presence of ZIKV in both plasma and cervical cytology of pregnant women. We report the identification of a population of pregnant women with a high incidence of ZIKV infection detected in the plasma and lower reproductive tract. A case-control study was performed to determine the incidence of ZIKV infection among low-income, pregnant women at risk for preterm delivery compared to matched controls. Plasma and cervical cytology specimens were tested for ZIKV by rRT-PCR. Fifty-nine pregnant women were enrolled. The incidence of ZIKV was 54% (32/59) overall: 18/31 (58.1%) in cases and 14/28 (50.0%) in controls. ZIKV detection in plasma and cervical cytology specimens demonstrated good agreement. Overall, outcomes for neonates born to ZIKV-positive and ZIKV-negative mothers were similar. However, two neonates were born with microcephaly to case mothers who were ZIKV positive. We report a high incidence of ZIKV infection (54%) in a distinctive population in Guayaquil, Ecuador. We identify ZIKV in cervical samples that correlates with ZIKV in the plasma.
These data raise concerns regarding the breadth of the ZIKV epidemic in Ecuador and demonstrate the utility of cervical cytology specimens for ZIKV testing. The purpose of this study was to identify infectious diseases more frequently associated among women at risk for preterm delivery.
Given the well-documented effects of ZIKV in pregnancy, including microcephaly and other fetal brain defects 2, 3 and the more recent report by Prisant et al. 4 demonstrating its presence in the female genital tract, we tested for the presence of ZIKV in both plasma and cervical cytology specimens of pregnant women using a validated, laboratorydeveloped molecular assay. 1, 5 Pregnancy outcomes for ZIKV-positive and ZIKV-negative mothers were compared.
In this study, we identify high incidence of ZIKV infection in a distinctive population in Guayaquil, Ecuador, and establish its presence in the plasma and cervical samples. 
| MATERIALS AND METHODS

| Ethics statement
| Cases and controls
Women in the third trimester of pregnancy were identified for enrollment in this study. The original study design was to identify infections that occurred at a higher frequency among women at risk for premature Neonatal outcome data were collected from the medical record.
Specifically, we recorded data on the following variables: method of delivery, gestational age at delivery, gender, APGAR scores, weight and size at the time of delivery, head circumference, the presence of jaundice, or recorded neurologic deficits.
| Clinical Samples
One peripheral blood sample and one cervical cytology specimen were obtained on a single day from each patient. Samples were collected between 22 and 37 weeks of gestation. Blood was drawn into EDTA collection tubes. Plasma was prepared from each sample, transported to the Molecular Biology Laboratory at Hospital Luis Vernaza, and stored at −4°C until processed. Cervical samples were obtained using Rovers Cervex Brushes. Samples were collected in SurePath Transportation
Media and stored at ambient temperature until processed.
| Nucleic Acid Extraction and Molecular Testing
RNA extraction was performed ≤7 days after sample collection. RNA was extracted from 140μl plasma using the QIAamp Viral RNA Mini kit (Qiagen) and a 60-μL elution volume, according to manufacturer instructions. RNA extracts were stored at −20°C until use. NucleoSpin
Tissue kits (Macherey-Nagel, Duren, Germany) were used to extract nucleic acids from the cervical cytology samples, following the protocol designed for the extraction of nucleic acids from cellular cultures.
Plasma and cervical cytology samples were tested for ZIKV using an internally controlled, multiplex real-time reverse transcription polymerase chain reaction (rRT-PCR) for ZIKV, chikungunya virus, and dengue virus (ZCD assay). 1, 5 The assay was performed on a Cobas Z 480 instrument (Roche Diagnostics) using the Users Defined Format (UDF) as previously described. 
| Statistical analysis
Categorical variables were compared for cases and controls using
Fisher's exact test, and continuous variables were compared by t-test.
To compare agreement between ZIKV detection in plasma versus cervical cytology specimens, a kappa statistic was calculated. Basic statistics were performed using Excel software. Fisher's exact tests, t tests and the kappa statistic were calculated using GraphPad software.
| RESULTS
Women were recruited for this study between June 1, 2016, and July 
| ZIKV detection in plasma and cervical cytology specimens
The overall incidence of ZIKV in this group of pregnant women was 54.2% (32/59). When we examined the plasma of these patients, we
found that 28 patients (28/59) were ZIKV positive and 31 ZIKV negative (31/59). When we examined the cervical samples from the same patients, we found 27 (27/59) patients ZIKV positive and 32 ZIKV negative (32/59). A comparison of ZIKV detection using plasma and cervical cytology specimens is shown in Table 3 . These specimen types demonstrated good agreement for the detection of ZIKV RNA (κ=0.69, 95% CI: 0.51-0.89).
We then examined the potential factors that may explain the concordance between the results obtained from the plasma and the cervical cytology. ZIKV-positive patients with concordant results (n=23)
were similar to patients with discordant results (n=9) with regard to age at enrollment, age at menarche, gestational age of the pregnancy, age at first sexual activity, and number of sexual partners (data not shown 
| Neonatal outcomes
Data were available for neonates born to 20/31 (64.5%) cases and 25/28 (89.3%) controls (Table 4) . Neonates born to case mothers were, on average, smaller than children born to controls. These children had lower birthweights and smaller head circumferences and were shorter, despite having similar gestational ages. Two neonates were born with head circumferences ≤31.2 cm, which was used as the cutoff for microcephaly 
T A B L E 1 Patient characteristics for cases (women at risk of preterm birth) and controls
T A B L E 2 Characteristics of patients based on ZIKV infection status
| DISCUSSION
In the present study, we report a high incidence of ZIKV infection in a distinctive population in Guayaquil, Ecuador. Furthermore, we de- Notably, two neonates that meet our definition of microcephaly (head circumference ≤31.2 cm), which was calculated based on published data from Hispanic Americans
6
, were born to ZIKV-positive mothers. The high incidence of ZIKV infection in our patients plus the detection of two cases of ZIKV-associated microcephaly in a short period of time raises concern that the extent of the ZIKV epidemic in Guayaquil has been greatly underappreciated. Additionally, the burden of ZIKV is likely being borne by the poorest members of society.
In summary, we report a high incidence of ZIKV infection in a highrisk population, which showed detectable ZIKV in cervical specimens.
Our findings strongly suggest the need to identify high-risk populations and monitor for the potential sexual transmission of the virus through screening of cervical specimens.
| CONCLUSIONS
ZIKV infections were identified in 54% of pregnant women from a low-income population in Guayaquil, Ecuador. ZIKV RNA was detected in both plasma and cervical cytology specimens with good agreement. These data raise concerns regarding the breadth of the ZIKV epidemic in Ecuador, demonstrate the utility of cervical cytology specimens for ZIKV testing, and provide supporting evidence for female-to-male virus transmission.
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